Actually I would be cautious. Allegra is fairly susceptible to DDI's (drug to drug interactions), and it is metabolized by cytochrome p450 3a4 which is exactly what one of augmentors goals is (inhibition).
I am not a pharmacist by the way. Just an educated opinion.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.